Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system (2017)

  • Authors:
  • USP affiliated authors: GHISLENI, DANIELA DAL MOLIM - FCF ; KIKUCHI, IRENE SATIKO - FCF ; PINTO, TEREZINHA DE JESUS ANDREOLI - FCF
  • USP Schools: FCF; FCF; FCF
  • DOI: 10.1007/s13346-016-0334-7
  • Subjects: FARMACOCINÉTICA; BETA-BLOQUEADORES
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s13346-016-0334-7 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Versões disponíveis em Acesso Aberto do: 10.1007/s13346-016-0334-7 (Fonte: Unpaywall API)

    Título do periódico: Drug Delivery and Translational Research

    ISSN: 2190-393X,2190-3948



      Não possui versão em Acesso aberto

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MALIPEDDI, Venkata Ramana; AWASTHI, Rajendra; GHISLENI, Daniela Dal Molim; et al. Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system. Drug Delivery and Translational Research, Heidelberg, v. 7, n. 1, p. 66-76, 2017. Disponível em: < http://dx.doi.org/10.1007/s13346-016-0334-7 > DOI: 10.1007/s13346-016-0334-7.
    • APA

      Malipeddi, V. R., Awasthi, R., Ghisleni, D. D. M., Braga, M. de S., Kikuchi, I. S., Pinto, T. de J. A., & Dua, K. (2017). Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system. Drug Delivery and Translational Research, 7( 1), 66-76. doi:10.1007/s13346-016-0334-7
    • NLM

      Malipeddi VR, Awasthi R, Ghisleni DDM, Braga M de S, Kikuchi IS, Pinto T de JA, Dua K. Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system [Internet]. Drug Delivery and Translational Research. 2017 ; 7( 1): 66-76.Available from: http://dx.doi.org/10.1007/s13346-016-0334-7
    • Vancouver

      Malipeddi VR, Awasthi R, Ghisleni DDM, Braga M de S, Kikuchi IS, Pinto T de JA, Dua K. Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system [Internet]. Drug Delivery and Translational Research. 2017 ; 7( 1): 66-76.Available from: http://dx.doi.org/10.1007/s13346-016-0334-7

    Referências citadas na obra
    Sareen R, Jain N, Kumar D. An insight to osmotic drug delivery. Curr Drug Deliv. 2012;9(3):285–96.
    Awasthi R, Kulkarni GT. Decades of research in drug targeting to the upper gastrointestinal tract using gastroretention technologies: where do we stand? Drug Deliv. 2016;23(2):378–94.
    Jain NK. Advances in controlled and novel drug delivery. 1st ed: CBS Publishers and Distributors; 2001. p. 426–36.
    Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. Challenges and opportunities in dermal/transdermal delivery. Ther Deliv. 2010;1(1):109–31.
    Ahad A, Al-Jenoobi FI, Al-Mohizea AM, Akhtar N, Raish M, Aqil M. Systemic delivery of β-blockers via transdermal route for hypertension. Saudi Pharm J. 2015;23(6):587–602.
    Nguyen KT, Ita KB, Parikh SJ, Popova IE, Bair DA. Transdermal delivery of captopril and metoprolol tartrate with microneedles. Drug Delivery Letters. 2014;4(3):236–43.
    Bhatt DC, Dhake AS, Khar RK, Mishra DN. Development and in-vitro evaluation of transdermal matrix films of metoprolol tartrate. Yakugaku Zasshi. 2008;128(9):1325–31.
    Aqil M, Sultana Y, Ali A, Dubey K, Najmi AK, Pillai KK. Transdermal drug delivery systems of a beta blocker: design, in vitro, and in vivo characterization. Drug Deliv. 2004;11(1):27–31.
    Aqil M, Ali A, Sultana Y, Saha N. Comparative bioavailability of metoprolol tartrate after oral and transdermal administration in healthy male volunteers. Clinical Drug Investigation. 2007;27(12):833–9.
    Aqil M, Sultana Y, Ali A. Matrix type transdermal drug delivery systems of metoprolol tartrate: In vitro characterization. Acta Pharma. 2003;53:119–25.
    Sankar V, Johnson DB, Sivanand V, Ravichandran V, Raghuram S. Design and evaluation of nifedipine transdermal films. Indian J Pharm Sci. 2003;65:510–5.
    Shinde AJ, Shinde AL, More HN. Design and evaluation of transdermal drug delivery system of gliclazide. Asian J Pharm. 2010;4:121–9.
    Manvi FV, Dandagi PM, Gadad AP, Mastiholimath VS, Jagadesh T. Formulation of a transdermal drug delivery system of ketotifen fumarate. Indian J Pharm Sci. 2003;65:239–43.
    Lec ST, Yac SH, Kim SW, Berner B. One way membrane for transdermal drug delivery system. II. System optimization. Int J Pharm. 1991;77(2–3):231–7.
    Lewis S, Pandey S, Udupa N. Design and evaluation of matrix type and membrane controlled transdermal delivery systems of nicotine suitable for use in smoking cessation. Indian J Pharm Sci. 2006;68:179–84.
    Satheeshababu BK, Shivakumar KL. Synthesis of conjugated chitosan and its effect on drug permeation from transdermal films. Indian J Pharm Sci. 2013;75(2):162–70.
    Dua K, Pabreja K, Ramana MV. Aceclofenac topical dosage forms: in vitro and in vivo characterization. Acta Pharma. 2010;60:467–78.
    Gungor S, Bektas A, Alp FI, Uydes-Dogan BS, Ozdemir O, Araman A, et al. Matrix-type transdermal films of verapamil hydrochloride: in vitro permeation studies through excised rat skin and pharmacodynamic evaluation in rats. Pharm Dev Technol. 2008;13(4):283–9.
    Dua K, Chakravarthi S, Kumar D, Sheshala R, Gupta G. Formulation, characterization, in vitro, in vivo, and histopathological evaluation of transdermal drug delivery containing norfloxacin and Curcuma longa. International Journal of Pharmaceutical Investigation. 2013;3:183–7.
    Dua K, Ramana MV, Madan J, Gupta G, Chakravarthi S, Awasthi R, et al. Norfloxacin and metronidazole topical formulations for effective treatment of bacterial infections and burn wounds. Interventional Medicine and Applied Science. 2016;8(2):68–76.
    Jibry N, Murdan S. In vivo investigation, in mice and in man, in to the irritation potential of novel amphiphilogels being studied as transdermal drug carriers. Eur J Pharm Biopharm. 2004;58:107–19.
    Aqil M, Zafar S, Ali A, Ahmad S. Transdermal drug delivery of labetolol hydrochloride: system development, in vitro, ex vivo and in vivo characterization. Curr Drug Deliv. 2005;2:125–31.